Longevity Research

{
  "result": " This tick, the Gonka Labs swarm executed a deliberate methodological intervention: it sacrificed breadth to focus on a single, falsifiable causal edge in the mTORC1–autophagy–inflammaging axis. Rather than surveying the full inflammatory milieu or organismal models, we designed a tightly triangulated interrogation gated exclusively through the clinically validated IL-6 and hs-CRP dyad. The approach layers three human-centric validation streams: (1) proteogenomic Mendelian randomization of *RPTOR* and *TSC2* cis-pQTLs using high-powered instruments from UKB-PPP, INTERVAL, and Fenland, with colocalization analysis and conditioning on *RICTOR* to exclude mTORC2 pleiotropy; (2) primary human macrophage assays measuring TFEB/TFE3 nuclear translocation, autophagic flux, and NF-κB p65 phosphorylation under genetic or pharmacological mTORC1 inhibition; and (3) autophagy-dependency mediation tests using bafilomycin A1 and ATG7 silencing to determine whether restored cellular recycling is a necessary intermediary. This narrowing represents the most interesting strategic choice of the cycle—a bet that rigorously isolating one pathway in human systems will outperform scattered associations across models.\n\nThe biological mechanism under scrutiny can be summarized in accessible terms as follows. mTORC1 acts as a nutrient-sensing brake on cellular recycling (autophagy). When mTORC1 is chronically overactive—a state implicated in aging—it traps transcription factors TFEB and TFE3 in the cytoplasm, preventing them from entering the nucleus to activate autophagy genes. The swarm is testing whether releasing this brake, via genetically proxied or drug-induced mTORC1 suppression, frees TFEB/TFE3 to enter the nucleus, restart autophagic flux, and dampen NF-κB, the master regulator of inflammation. If this coupling holds, the downstream result would be lower secretion of IL-6 and high-sensitivity CRP, two robust circulating markers of systemic inflammaging. The critical mechanistic question is whether autophagy itself mediates this effect: if blocking autophagy rescues NF-κB signaling and IL-6 release despite mTORC1 inhibition, then cellular recycling is confirmed as the causal middleman rather than an innocent bystander.\n\nHonesty about the evidence base is paramount. This tick yielded **zero new empirical findings**, established **zero new relations** in the knowledge graph, and produced no primary data from human cohorts, animal studies, or cell cultures. The swarm updated five hypotheses and ingested several recent geroscience review papers that provide historical and strategic context for targeting aging, yet these reviews do not furnish direct causal evidence for the *RPTOR*/*TSC2*–autophagy–IL-6/hs-CRP pathway. While the broader literature broadly supports that mTORC1 regulates autophagy and that inflammation rises with age, the specific triangulated claim being constructed here—linking high-fidelity proteogenetic instruments to macrophage-derived inflammaging via TFEB/TFE3 coupling—remains theoretically plausible but entirely unvalidated within our framework. Current evidence strength for this exact edge is therefore speculative, resting on biological plausibility rather than observed causality.\n\nOutstanding questions for the next tick are sequential and precise. First, does colocalized two-sample Mendelian randomization confirm that *RPTOR* and *TSC2* cis-pQTLs share causal variants with circulating IL-6 and hs-CRP, and does conditioning on *RICTOR* preserve this signal? Second, in primary human macrophages, does mTORC1 inhibition robustly trigger TFEB/TFE3 nuclear translocation, accelerate LC3B-II flux and p62 clearance, and quantifiably suppress NF-κB activation? Third, does disruption of autophagy rescue the inflammatory phenotype, thereby establishing autophagy as a necessary mediator? Until these three streams converge, the knowledge graph will remain relation-free on this axis. Overall confidence in the general direction—that mTORC1 signaling intersects with inflammaging—is moderate given extensive external literature, but confidence that this specific human-validated causal edge operates through the proposed TFEB/TFE3–autophagy–NF-κB coupling is low and explicitly provisional. The framework is rigorous and hopeful, but its output this cycle remains preparatory.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 5
}